Physician profile
Stephen Cohn
NPI 1982711966
$615.08
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $174 · 2021: $149 · 2022: $104.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $126.59 | 2019 | |
| Polarityte, INC. | $106.82 | 2020-2021 | |
| Ethicon US, LLC | $84.54 | 2021 | |
| Smith+Nephew, INC. | $83.29 | 2020-2021 | |
| Integra Lifesciences Corporation | $75.29 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $34.12 | 2019 | |
| Kerecis Limited | $28.66 | 2022 | |
| Masimo Corporation | $19.09 | 2020 | |
| Acell, INC. | $15.32 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.12 | 2020 | |
| Portola Pharmaceuticals, LLC | $13.62 | 2019 | |
| Shire North American Group INC | $13.62 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.